Demand for Endoluminal Suturing Device in USA

Demand for Endoluminal Suturing Device in USA Forecast and Outlook 2025 to 2035

The demand for endoluminal suturing devices in the USA is projected at USD 32.4 million in 2025, with expectations to reach USD 55.0 million by 2035, marking a compound annual growth rate (CAGR) of 5.4%. The growth is fueled by the increasing adoption of minimally invasive surgical techniques, especially in gastrointestinal and bariatric procedures. The rising prevalence of conditions such as obesity and colorectal cancer is driving the demand for these devices. Furthermore, advancements in device technology, including improved accuracy and safety, have encouraged more widespread use in surgeries. As healthcare providers continue to recognize the advantages of these tools, their integration into surgical practices is expected to increase, contributing to overall market growth.

The market for endoluminal suturing devices is expected to experience gradual, consistent growth, moving from USD 24.9 million in earlier years to USD 32.4 million by 2025, and ultimately reaching USD 55.0 million by 2035. Each year, the demand is anticipated to rise incrementally, reflecting an expanding adoption of the devices across various healthcare settings. With growing awareness of their benefits and continuous technological improvements, the demand for these devices will continue to strengthen. By 2035, the sector will likely see larger annual increases as endoluminal suturing devices become more common in surgeries, further solidifying their role in modern surgical practices.

Quick Stats of the Demand for Endoluminal Suturing Devices in USA:

• Demand for Endoluminal Suturing Devices in USA Value (2025): USD 32.4 million
• Demand for Endoluminal Suturing Devices in USA Forecast Value (2035): USD 55.0 million
• Demand for Endoluminal Suturing Devices in USA Forecast CAGR (2025–2035): 5.4%
• Leading Application by Demand: Bariatric Procedures (53%)
• Key Growth Regions for Endoluminal Suturing Devices: West, South, Northeast, Midwest
• Top Players in Endoluminal Suturing Devices Industry: Boston Scientific Corporation, Medtronic, Olympus, Ovesco Endoscopy AG, EndoRobotics Co., LTD.

What is the Growth Forecast for Demand for Endoluminal Suturing Device in USA through 2035?

Demand in USA for endoluminal suturing devices is expected to increase from USD 32.4 million in 2025 to USD 55.0 million by 2035, reflecting a compound annual growth rate (CAGR) of approximately 5.4%. From USD 24.9 million in 2020, demand rises modestly to USD 30.8 million in 2024 and then to USD 32.4 million in 2025. Between 2025 and 2030, demand will grow to about USD 40.0 million, followed by continued expansion to USD 55.0 million in 2035. This growth is supported by an increasing preference for minimally invasive surgical techniques and expanding applications in gastrointestinal, bariatric and refluxrelated surgeries.

Technologydriven enhancement of these devices and increased adoption of advanced endoscopic procedures are important demand drivers. As surgeons pursue less invasive options with faster recovery, the usage of suturing devices capable of internal tissue approximation grows. Additionally, the rise in obesity and gastrointestinal disorders increases surgical volumes. Over time, the device cost per procedure and complexity of applications both climb, supporting value expansion even if volume growth remains moderate. The combination of procedure growth, technical innovation and rising peruse spend underpins the forecast through 2035.

Endoluminal Suturing Device Industry in USA

Metric	Value
Industry Value (2025)	USD 32.4 million
Forecast Value (2035)	USD 55.0 million
Forecast CAGR (2025–2035)	5.4%

What Is Driving the Demand for Endoluminal Suturing Device in USA?

The demand for endoluminal suturing device in USA is largely influenced by the rising prevalence of minimally invasive surgical procedures. Surgeons and healthcare facilities increasingly prefer techniques that reduce patient recovery times and lower complication rates. Enhanced technology in suturing systems, including devices capable of closure via endoscopic access rather than open surgery, supports this shift. The growing incidence of gastrointestinal and bariatric procedures in USA also expands the need for devices capable of internal tissue approximation. Strong healthcare infrastructure and favourable reimbursement policies contribute to higher adoption of such advanced surgical tools.

Another factor supporting demand is ongoing innovation in device design and functionality. Newer endoluminal suturing devices offer improved accuracy, better ergonomic handling, and compatibility with outpatient surgical settings. As ambulatory surgical centres gain prominence, the demand for device formats suited for shorter stay procedures increases. Training and proficiency of surgeons in these advanced suturing techniques are improving which further facilitates uptake. Cost pressures and regulatory approval processes remain challenges but the overall trajectory for endoluminal suturing device demand in USA continues upwards.

What Factors Are Affecting the Demand for Endoluminal Suturing Devices in USA in Terms of Product Type and Application?

The demand for endoluminal suturing devices in the USA is driven by both the product types and the specific applications for which they are used. Product types include needle-based suturing devices and clip-based suturing devices, each offering distinct benefits depending on the complexity of the surgical procedure. Applications for these devices are categorized into bariatric, gastrointestinal repairs, and other procedures, which highlight the varying needs for suturing in different types of surgeries. These segments reflect the evolving landscape of minimally invasive surgeries, where precision and efficiency are key drivers of demand.

What Drives the Leading Demand for Needle-based Suturing Devices in USA?

Needle-based suturing devices account for 47% of the total demand for endoluminal suturing devices in the USA. These devices are favored for their versatility and precision in performing suturing during minimally invasive surgeries. Needle-based suturing devices are commonly used in bariatric surgery, gastrointestinal repairs, and other related procedures, where accurate stitching is required to ensure proper tissue healing and minimize complications. The high demand for needle-based devices is driven by the increasing preference for minimally invasive techniques in surgical procedures, offering patients faster recovery times and reduced risks.

The demand for needle-based suturing devices is also influenced by technological advancements that have improved their design, making them easier to use and more effective in delivering secure sutures in delicate tissues. These devices provide surgeons with the control and flexibility needed for complex surgeries, contributing to their continued popularity. As the adoption of minimally invasive surgeries grows, needle-based suturing devices remain a key component in ensuring the success of these procedures.

What Drives the Demand for Bariatric Applications in Endoluminal Suturing Devices in USA?

Bariatric procedures represent 53.0% of the total demand for endoluminal suturing devices in the USA. This high demand is driven by the rising prevalence of obesity and the increasing number of bariatric surgeries performed annually. Bariatric surgeries, including gastric bypass and sleeve gastrectomy, require precise suturing to ensure the success of the procedure and minimize postoperative complications. As the focus on combating obesity through surgical interventions grows, the demand for reliable and effective suturing devices in bariatric surgeries continues to rise.

The growth in bariatric applications is also supported by the increasing acceptance of minimally invasive techniques in weight loss surgery. The ability to perform these procedures with smaller incisions and less trauma to surrounding tissues enhances patient outcomes and accelerates recovery. As bariatric surgeries become more widespread, the demand for endoluminal suturing devices tailored to these applications is expected to continue its upward trend, driven by both the health challenges associated with obesity and the benefits of advanced surgical technologies.

What factors are driving the growth of endoluminal suturing devices in USA?

The demand for endoluminal suturing devices in the USA is increasing as healthcare providers shift toward minimally invasive surgical techniques, especially for gastrointestinal and bariatric applications. High prevalence of obesity and related disorders has led to greater numbers of endoscopic sleeve gastroplasty and gastrointestinal defect repair procedures. Hospitals and ambulatory surgical centres are expanding their use of such devices to reduce patient recovery time, lower complication rates and shorten hospital stays. Technological advancements in endoscopic suturing systems and favourable reimbursement for minimally invasive approaches are also contributing to increased adoption.

What emerging opportunity is influencing the adoption of endoluminal suturing devices in USA?

An important opportunity for this device segment in the USA lies in its increasing application within outpatient and ambulatory surgical settings. As procedural volumes shift from inpatient hospitals toward lowercost outpatient environments, suturing systems designed for endoscopic use become more desirable. Devices that are singleuse, more compact or compatible with flexible endoscopes align with this trend. Additionally, improved training programmes for endoscopists and expanded indication such as for gastroesophageal reflux disease repair and nonsurgical weightloss interventions open new procedural markets for these suturing devices.

What challenges are limiting wider uptake of endoluminal suturing devices in USA?

Despite the growth potential, certain constraints slow broad adoption of endoluminal suturing devices in the USA. These include the high cost of advanced suturing systems and the need for surgeon training, both of which raise the total cost of ownership for healthcare facilities. Some institutions may also hesitate due to reimbursement uncertainties for newer procedural applications. In addition, competition from alternative closure technologies such as staplers and clips may reduce preference for specialised suturing systems in some cases. These factors together restrict uptake across smaller facilities and lessestablished clinical practices.

What is the Demand for Endoluminal Suturing Device in USA by Region?

Region	CAGR (%)
West	6.2%
South	5.6%
Northeast	5.0%
Midwest	4.3%

The demand for endoluminal suturing devices in the USA is showing strong growth across all regions. The West leads with a 6.2% CAGR, driven by advanced healthcare facilities, a high concentration of medical research centers, and a growing adoption of minimally invasive procedures. The South follows with a 5.6% growth, supported by expanding healthcare networks and rising demand for innovative surgical technologies. The Northeast, growing at 5.0%, benefits from its large medical device sector, prominent healthcare institutions, and high levels of procedural adoption. The Midwest, with a 4.3% CAGR, experiences steady growth, driven by increasing surgical procedures and a focus on enhancing surgical efficiency in hospitals.

How Is the West Region Driving Demand for Endoluminal Suturing Devices?

The West region of the USA is projected to grow at a CAGR of 6.2% through 2035 in demand for endoluminal suturing devices. The region’s leading healthcare infrastructure and advanced medical facilities drive demand for these devices, particularly in states like California and Nevada, where cutting-edge surgical techniques are widely adopted. The rise in minimally invasive surgeries, especially in the fields of gastroenterology and colorectal surgery, further contributes to this demand. Additionally, the increasing number of surgeries requiring suturing for wound closure in endoluminal procedures accelerates the market’s growth.

• Advanced healthcare infrastructure and medical facilities drive device demand.
• Growth in minimally invasive surgeries fuels adoption of suturing devices.
• States like California and Nevada lead in advanced surgical techniques.
• Increasing number of endoluminal surgeries accelerates demand for suturing devices.

How Is the South Region Supporting Demand for Endoluminal Suturing Devices?

The South region of the USA is projected to grow at a CAGR of 5.6% through 2035 in demand for endoluminal suturing devices. As healthcare facilities and medical centers expand across states like Texas and Florida, the need for advanced surgical tools, including endoluminal suturing devices, increases. The rise in surgical procedures, particularly minimally invasive treatments for gastrointestinal and colorectal conditions, further drives the market. Additionally, the growing adoption of robotic surgeries and advancements in surgical technology contribute to the increased use of these specialized devices in clinical settings.

• Expanding healthcare facilities in Texas and Florida drive device adoption.
• Rise in minimally invasive surgeries fuels demand for suturing tools.
• Robotic surgeries and technological advancements contribute to market growth.
• Increasing number of surgeries requiring suturing drives demand for devices.

How Is the Northeast Region Contributing to Demand for Endoluminal Suturing Devices?

The Northeast region of the USA is projected to grow at a CAGR of 5% through 2035 in demand for endoluminal suturing devices. With a strong concentration of renowned medical institutions and research hospitals in states like New York and Massachusetts, the Northeast is at the forefront of adopting advanced surgical technologies. The region’s focus on minimally invasive procedures and the rising incidence of gastrointestinal and colorectal diseases contribute to the growing demand for suturing devices. The region’s emphasis on innovation in healthcare also supports the adoption of these specialized tools.

• Renowned medical institutions in New York and Massachusetts drive adoption.
• Emphasis on minimally invasive procedures boosts demand for suturing devices.
• Growing incidence of gastrointestinal and colorectal diseases drives market growth.
• Healthcare innovation supports the adoption of advanced suturing devices.

How Is the Midwest Region Supporting Demand for Endoluminal Suturing Devices?

The Midwest region of the USA is projected to grow at a CAGR of 4.3% through 2035 in demand for endoluminal suturing devices. As the region’s healthcare sector continues to expand, particularly in states like Illinois and Michigan, the need for specialized surgical devices rises. The Midwest’s focus on minimally invasive procedures, especially in the field of gastrointestinal surgery, contributes to the adoption of endoluminal suturing devices. Additionally, increasing healthcare investments and technological advancements in surgical equipment continue to fuel the demand for these devices in clinical settings.

• Healthcare sector expansion in Illinois and Michigan drives device demand.
• Focus on minimally invasive procedures increases demand for suturing tools.
• Growth in gastrointestinal surgeries drives demand for specialized suturing devices.
• Investments in healthcare and surgical technology fuel device adoption.

What is driving the demand for Endoluminal suturing devices in USA and who are the key players shaping the industry?

The demand for endoluminal suturing devices in the USA is driven by the increasing adoption of minimally invasive surgical procedures for gastrointestinal conditions. The prevalence of disorders such as obesity, gastroesophageal reflux disease and gastrointestinal cancers is rising, prompting greater need for devices that enable internal tissue closure without large incisions. Technological improvements in device design, robotic assistance and imaging integration support wider use in hospital and ambulatory surgical centre settings. The robust healthcare infrastructure and favourable reimbursement environment in the USA further support adoption of such advanced surgical tools.

Key players active in the USA market include Boston Scientific Corporation, Medtronic, Olympus Corporation, Ovesco Endoscopy AG and EndoRobotics Co., LTD.. These firms provide a variety of endoluminal suturing systems and related technologies tailored for procedures in bariatric surgery, gastrointestinal defect closure and anastomosis. They compete on procedural compatibility, device precision and training support for surgical teams. Their strategic emphasis on innovation and clinician education positions them to shape the growth trajectory of this device category.

Key Players in Endoluminal suturing devices Industry in USA

• Boston Scientific Corporation
• Medtronic
• Olympus
• Ovesco Endoscopy AG
• EndoRobotics Co., LTD.

Report Scope for Endoluminal suturing devices Industry in USA

Items	Values
Quantitative Units (2025)	USD million
Product Type	Needle-based Suturing Devices, Clip-based Suturing Devices
Application	Bariatric, Gastrointestinal Repairs, Others
End User	Hospitals, Ambulatory Surgery Centers (ASCs), Specialty Clinics, Specialty Surgical Centers, Cancer Treatment Centers
Regions Covered	Northeast, West, Midwest, South
Countries Covered	USA
Key Companies Profiled	Boston Scientific Corporation, Medtronic, Olympus, Ovesco Endoscopy AG, EndoRobotics Co., LTD.
Additional Attributes	Dollar by sales across product types, applications, and end-users; technological advancements in suturing systems; regional demand trends; surgical procedure adoption rates; training and clinician support dynamics.

Endoluminal suturing devices Industry in USA Segmentation

Product Type:

• Needle-based Suturing Devices
• Clip-based Suturing Devices

Application:

• Bariatric
• Gastrointestinal Repairs
• Others

End User:

• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Specialty Clinics
• Specialty Surgical Centers
• Cancer Treatment Centers

Region 

• Northeast 
• West 
• Midwest 
• South